Annual SG&A
$31.15 M
+$1.99 M+6.81%
31 December 2023
Summary:
Trinity Biotech annual selling, general & administrative expenses is currently $31.15 million, with the most recent change of +$1.99 million (+6.81%) on 31 December 2023. During the last 3 years, it has risen by +$3.65 million (+13.28%). TRIB annual SG&A is now -56.32% below its all-time high of $71.33 million, reached on 31 December 2007.TRIB Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$6.52 M
+$94.00 K+1.46%
30 September 2024
Summary:
Trinity Biotech quarterly selling, general & administrative expenses is currently $6.52 million, with the most recent change of +$94.00 thousand (+1.46%) on 30 September 2024. Over the past year, it has dropped by -$1.16 million (-15.15%). TRIB quarterly SG&A is now -50.95% below its all-time high of $13.29 million, reached on 31 December 2013.TRIB Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$219.88 M
-$20.16 M-10.10%
30 September 2024
Summary:
Trinity Biotech TTM selling, general & administrative expenses is currently -$219.88 million, with the most recent change of -$20.16 million (-10.10%) on 30 September 2024. Over the past year, it has dropped by -$253.77 million (-748.80%). TRIB TTM SG&A is now -127.30% below its all-time high of $48.54 million, reached on 31 December 2008.TRIB TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.8% | -15.2% | -748.8% |
| 3 y3 years | +13.3% | +6.6% | -865.3% |
| 5 y5 years | +5.7% | -13.4% | -885.4% |
TRIB Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.2% | -32.6% | +91.6% | -532.0% | at low |
| 5 y | 5 years | -4.7% | +26.2% | -44.0% | +91.6% | -204.1% | at low |
| alltime | all time | -56.3% | +1316.0% | -51.0% | +986.2% | -127.3% | +42.2% |
Trinity Biotech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.52 M(+1.5%) | $27.38 M(-4.1%) |
| June 2024 | - | $6.42 M(-14.4%) | $28.54 M(-4.9%) |
| Mar 2024 | - | $7.50 M(+8.2%) | $30.02 M(-3.6%) |
| Dec 2023 | $31.15 M(+6.8%) | $6.93 M(-9.7%) | $31.15 M(-8.1%) |
| Sept 2023 | - | $7.68 M(-2.8%) | $33.89 M(+8.1%) |
| June 2023 | - | $7.91 M(-8.4%) | $31.36 M(+6.7%) |
| Mar 2023 | - | $8.63 M(-10.8%) | $29.38 M(+8.9%) |
| Dec 2022 | $29.17 M(+18.2%) | $9.67 M(+87.8%) | $26.98 M(+30.3%) |
| Sept 2022 | - | $5.15 M(-13.1%) | $20.71 M(-4.4%) |
| June 2022 | - | $5.93 M(-4.9%) | $21.68 M(-3.0%) |
| Mar 2022 | - | $6.23 M(+83.3%) | $22.34 M(-0.7%) |
| Dec 2021 | $24.68 M(-10.2%) | $3.40 M(-44.4%) | $22.50 M(-21.7%) |
| Sept 2021 | - | $6.11 M(-7.3%) | $28.73 M(-1.1%) |
| June 2021 | - | $6.59 M(+3.0%) | $29.05 M(+5.0%) |
| Mar 2021 | - | $6.40 M(-33.6%) | $27.68 M(+0.7%) |
| Dec 2020 | $27.50 M(-15.9%) | $9.63 M(+49.8%) | $27.50 M(-6.8%) |
| Sept 2020 | - | $6.43 M(+23.2%) | $29.51 M(-3.6%) |
| June 2020 | - | $5.22 M(-16.1%) | $30.60 M(-4.9%) |
| Mar 2020 | - | $6.22 M(-46.6%) | $32.19 M(-1.6%) |
| Dec 2019 | $32.70 M(+10.9%) | $11.64 M(+54.7%) | $32.70 M(+16.8%) |
| Sept 2019 | - | $7.53 M(+10.6%) | $28.00 M(+0.2%) |
| June 2019 | - | $6.81 M(+1.2%) | $27.95 M(-3.1%) |
| Mar 2019 | - | $6.73 M(-3.0%) | $28.83 M(-2.2%) |
| Dec 2018 | $29.48 M(+1.8%) | $6.93 M(-7.3%) | $29.48 M(+3.4%) |
| Sept 2018 | - | $7.48 M(-2.7%) | $28.50 M(-1.9%) |
| June 2018 | - | $7.69 M(+4.2%) | $29.05 M(-0.0%) |
| Mar 2018 | - | $7.37 M(+23.8%) | $29.05 M(+0.3%) |
| Dec 2017 | $28.94 M(+5.7%) | $5.96 M(-25.8%) | $28.95 M(-5.3%) |
| Sept 2017 | - | $8.03 M(+4.4%) | $30.58 M(+1.0%) |
| June 2017 | - | $7.69 M(+5.7%) | $30.28 M(-1.9%) |
| Mar 2017 | - | $7.28 M(-4.0%) | $30.85 M(+0.2%) |
| Dec 2016 | $27.39 M(-2.9%) | $7.58 M(-1.8%) | $30.80 M(+4.7%) |
| Sept 2016 | - | $7.72 M(-6.6%) | $29.41 M(-0.2%) |
| June 2016 | - | $8.27 M(+14.3%) | $29.48 M(+3.8%) |
| Mar 2016 | - | $7.23 M(+16.7%) | $28.40 M(+1.4%) |
| Dec 2015 | $28.23 M(+1.9%) | $6.19 M(-20.5%) | $28.02 M(-1.9%) |
| Sept 2015 | - | $7.79 M(+8.5%) | $28.57 M(+1.7%) |
| June 2015 | - | $7.19 M(+5.0%) | $28.09 M(+1.2%) |
| Mar 2015 | - | $6.84 M(+1.5%) | $27.77 M(+0.3%) |
| Dec 2014 | $27.69 M(-11.1%) | $6.74 M(-7.9%) | $27.69 M(-19.1%) |
| Sept 2014 | - | $7.32 M(+6.7%) | $34.24 M(+2.8%) |
| June 2014 | - | $6.86 M(+1.3%) | $33.32 M(+2.8%) |
| Mar 2014 | - | $6.77 M(-49.1%) | $32.40 M(+4.0%) |
| Dec 2013 | $31.16 M(+48.8%) | $13.29 M(+107.5%) | $31.16 M(+42.5%) |
| Sept 2013 | - | $6.40 M(+7.8%) | $21.87 M(+3.8%) |
| June 2013 | - | $5.94 M(+7.4%) | $21.07 M(+0.7%) |
| Mar 2013 | - | $5.53 M(+38.6%) | $20.93 M(-0.0%) |
| Dec 2012 | $20.94 M(+1.6%) | $3.99 M(-28.8%) | $20.94 M(-0.6%) |
| Sept 2012 | - | $5.61 M(-3.4%) | $21.07 M(+0.6%) |
| June 2012 | - | $5.80 M(+4.7%) | $20.95 M(+1.2%) |
| Mar 2012 | - | $5.54 M(+34.7%) | $20.69 M(+0.4%) |
| Dec 2011 | $20.62 M(-18.6%) | $4.12 M(-25.0%) | $20.62 M(-0.1%) |
| Sept 2011 | - | $5.49 M(-1.1%) | $20.64 M(-2.9%) |
| June 2011 | - | $5.55 M(+1.5%) | $21.27 M(-6.3%) |
| Mar 2011 | - | $5.47 M(+32.2%) | $22.69 M(-10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | $25.34 M(-29.6%) | $4.13 M(-32.4%) | $25.34 M(-14.1%) |
| Sept 2010 | - | $6.11 M(-12.4%) | $29.49 M(-8.5%) |
| June 2010 | - | $6.98 M(-14.0%) | $32.22 M(-6.4%) |
| Mar 2010 | - | $8.12 M(-2.1%) | $34.43 M(-4.4%) |
| Dec 2009 | $36.01 M(-24.7%) | $8.29 M(-6.2%) | $36.01 M(-9.6%) |
| Sept 2009 | - | $8.84 M(-3.8%) | $39.84 M(-7.6%) |
| June 2009 | - | $9.19 M(-5.3%) | $43.12 M(-6.3%) |
| Mar 2009 | - | $9.70 M(-19.9%) | $46.02 M(-5.2%) |
| Dec 2008 | $47.82 M(-33.0%) | $12.11 M(-0.1%) | $48.54 M(+33.3%) |
| Sept 2008 | - | $12.12 M(+0.3%) | $36.43 M(+49.9%) |
| June 2008 | - | $12.08 M(-1.2%) | $24.31 M(-2.3%) |
| Mar 2008 | - | $12.23 M(-3.5%) | $24.89 M(-48.5%) |
| Dec 2007 | $71.33 M(+68.1%) | - | - |
| June 2007 | - | $12.67 M(+2.5%) | $48.30 M(+6.9%) |
| Mar 2007 | - | $12.36 M(-1.9%) | $45.19 M(+6.5%) |
| Dec 2006 | $42.42 M(+22.4%) | $12.60 M(+18.1%) | $42.42 M(+9.2%) |
| Sept 2006 | - | $10.67 M(+11.8%) | $38.85 M(+3.2%) |
| June 2006 | - | $9.55 M(-0.5%) | $37.66 M(+3.9%) |
| Mar 2006 | - | $9.60 M(+6.3%) | $36.24 M(+7.0%) |
| Dec 2005 | $34.65 M(+18.1%) | $9.03 M(-4.7%) | $33.85 M(-1.2%) |
| Sept 2005 | - | $9.48 M(+16.6%) | $34.27 M(+7.5%) |
| June 2005 | - | $8.13 M(+12.7%) | $31.89 M(+3.4%) |
| Mar 2005 | - | $7.21 M(-23.7%) | $30.84 M(+5.1%) |
| Dec 2004 | $29.33 M(+63.7%) | $9.45 M(+33.1%) | $29.33 M(+15.0%) |
| Sept 2004 | - | $7.10 M(+0.3%) | $25.51 M(+12.6%) |
| June 2004 | - | $7.08 M(+24.0%) | $22.66 M(+15.9%) |
| Mar 2004 | - | $5.71 M(+1.4%) | $19.55 M(+9.1%) |
| Dec 2003 | $17.92 M(+17.6%) | $5.63 M(+32.6%) | $17.92 M(-8.7%) |
| Sept 2003 | - | $4.25 M(+6.8%) | $19.62 M(+7.3%) |
| June 2003 | - | $3.97 M(-2.5%) | $18.30 M(+8.2%) |
| Mar 2003 | - | $4.07 M(-44.4%) | $16.91 M(+11.0%) |
| Dec 2002 | $15.23 M(+15.4%) | $7.33 M(+151.2%) | $15.23 M(+4.7%) |
| Sept 2002 | - | $2.92 M(+12.7%) | $14.54 M(+5.9%) |
| June 2002 | - | $2.59 M(+8.1%) | $13.73 M(+1.2%) |
| Mar 2002 | - | $2.40 M(-63.9%) | $13.57 M(+6.0%) |
| Dec 2001 | $13.20 M(+155.9%) | $6.64 M(+215.0%) | $12.80 M(+53.4%) |
| Sept 2001 | - | $2.11 M(-13.0%) | $8.34 M(+14.8%) |
| June 2001 | - | $2.42 M(+48.8%) | $7.27 M(+22.7%) |
| Mar 2001 | - | $1.63 M(-25.5%) | $5.92 M(+14.9%) |
| Dec 2000 | $5.16 M(+29.9%) | $2.19 M(+112.1%) | $5.16 M(+11.1%) |
| Sept 2000 | - | $1.03 M(-4.4%) | $4.64 M(+5.2%) |
| June 2000 | - | $1.08 M(+25.1%) | $4.41 M(+6.7%) |
| Mar 2000 | - | $862.00 K(-48.4%) | $4.13 M(+4.1%) |
| Dec 1999 | $3.97 M(+58.8%) | $1.67 M(+108.7%) | $3.97 M(+36.9%) |
| Sept 1999 | - | $800.00 K(0.0%) | $2.90 M(+7.4%) |
| June 1999 | - | $800.00 K(+14.3%) | $2.70 M(+8.0%) |
| Mar 1999 | - | $700.00 K(+16.7%) | $2.50 M(+38.9%) |
| Dec 1998 | $2.50 M(-21.9%) | $600.00 K(0.0%) | $1.80 M(+50.0%) |
| Sept 1998 | - | $600.00 K(0.0%) | $1.20 M(+100.0%) |
| June 1998 | - | $600.00 K | $600.00 K |
| Dec 1997 | $3.20 M(+45.5%) | - | - |
| Dec 1996 | $2.20 M(-42.1%) | - | - |
| Dec 1995 | $3.80 M(+15.2%) | - | - |
| Dec 1994 | $3.30 M(-21.4%) | - | - |
| Feb 1994 | $4.20 M | - | - |
FAQ
- What is Trinity Biotech annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Trinity Biotech?
- What is Trinity Biotech annual SG&A year-on-year change?
- What is Trinity Biotech quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Trinity Biotech?
- What is Trinity Biotech quarterly SG&A year-on-year change?
- What is Trinity Biotech TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Trinity Biotech?
- What is Trinity Biotech TTM SG&A year-on-year change?
What is Trinity Biotech annual selling, general & administrative expenses?
The current annual SG&A of TRIB is $31.15 M
What is the all time high annual SG&A for Trinity Biotech?
Trinity Biotech all-time high annual selling, general & administrative expenses is $71.33 M
What is Trinity Biotech annual SG&A year-on-year change?
Over the past year, TRIB annual selling, general & administrative expenses has changed by +$1.99 M (+6.81%)
What is Trinity Biotech quarterly selling, general & administrative expenses?
The current quarterly SG&A of TRIB is $6.52 M
What is the all time high quarterly SG&A for Trinity Biotech?
Trinity Biotech all-time high quarterly selling, general & administrative expenses is $13.29 M
What is Trinity Biotech quarterly SG&A year-on-year change?
Over the past year, TRIB quarterly selling, general & administrative expenses has changed by -$1.16 M (-15.15%)
What is Trinity Biotech TTM selling, general & administrative expenses?
The current TTM SG&A of TRIB is -$219.88 M
What is the all time high TTM SG&A for Trinity Biotech?
Trinity Biotech all-time high TTM selling, general & administrative expenses is $48.54 M
What is Trinity Biotech TTM SG&A year-on-year change?
Over the past year, TRIB TTM selling, general & administrative expenses has changed by -$253.77 M (-748.80%)